| Product Code: ETC8836756 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Deep | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The Philippines saw a decline in CIS insulin import shipments in 2024, with top exporting countries being Switzerland, India, South Korea, Germany, and the USA. Despite the low concentration with a low Herfindahl-Hirschman Index (HHI), the market experienced a significant negative compound annual growth rate (CAGR) of -17.36% from 2020 to 2024. The growth rate in 2024 also plummeted by -47.02%, indicating a challenging year for the CIS insulin import market in the Philippines.

The CIS insulin market in the Philippines is growing as the prevalence of diabetes increases. Insulin is a vital treatment for managing blood glucose levels in diabetic patients, and with the rise in lifestyle-related health issues, demand for insulin and insulin delivery devices is expected to continue growing.
The CIS Insulin market in the Philippines is steadily growing, primarily driven by the increasing prevalence of diabetes in the population. With rising awareness about diabetes management, there is an increasing demand for insulin as a critical part of diabetes treatment. Technological advancements in insulin delivery systems, such as insulin pens and pumps, are gaining popularity, making treatment more convenient for patients. Additionally, the governments efforts to improve access to healthcare are expected to expand the insulin market in the region.
The Insulin market faces issues of affordability and equitable distribution, especially in rural areas where healthcare access is limited. Dependence on imported insulin brands exposes the market to price fluctuations and supply disruptions, while the prevalence of counterfeit products threatens patient safety.
The insulin market in the Philippines is expected to grow due to the rising number of diabetes cases. Investment opportunities lie in the production, distribution, and innovation of insulin therapies, particularly long-acting and rapid-acting formulations. Companies that focus on ensuring affordability and accessibility of insulin for the growing diabetic population in the Philippines will find promising opportunities in this market.
Government policies for the CIS insulin market focus on ensuring the availability of affordable insulin products for diabetic patients. The Department of Health, along with PhilHealth, supports initiatives to subsidize insulin and other essential diabetic medications. The government also works to improve healthcare infrastructure and access, particularly in rural areas, to address the needs of patients with chronic diseases such as diabetes.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines CIS Insulin Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines CIS Insulin Market Revenues & Volume, 2021 & 2031F |
3.3 Philippines CIS Insulin Market - Industry Life Cycle |
3.4 Philippines CIS Insulin Market - Porter's Five Forces |
3.5 Philippines CIS Insulin Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 Philippines CIS Insulin Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Philippines CIS Insulin Market Revenues & Volume Share, By Source, 2021 & 2031F |
4 Philippines CIS Insulin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of diabetes in the Philippines |
4.2.2 Rising awareness about insulin therapy and its benefits |
4.2.3 Technological advancements in insulin delivery devices |
4.3 Market Restraints |
4.3.1 High cost of insulin therapy |
4.3.2 Limited access to healthcare services in remote areas |
4.3.3 Regulatory challenges in the approval process for new insulin products |
5 Philippines CIS Insulin Market Trends |
6 Philippines CIS Insulin Market, By Types |
6.1 Philippines CIS Insulin Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Philippines CIS Insulin Market Revenues & Volume, By Application, 2021- 2031F |
6.1.3 Philippines CIS Insulin Market Revenues & Volume, By Type I Diabetes, 2021- 2031F |
6.1.4 Philippines CIS Insulin Market Revenues & Volume, By Type II Diabetes, 2021- 2031F |
6.2 Philippines CIS Insulin Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 Philippines CIS Insulin Market Revenues & Volume, By Rapid Acting, 2021- 2031F |
6.2.3 Philippines CIS Insulin Market Revenues & Volume, By Long Acting, 2021- 2031F |
6.2.4 Philippines CIS Insulin Market Revenues & Volume, By Short Acting, 2021- 2031F |
6.2.5 Philippines CIS Insulin Market Revenues & Volume, By Intermediate Acting, 2021- 2031F |
6.2.6 Philippines CIS Insulin Market Revenues & Volume, By Premixed, 2021- 2031F |
6.3 Philippines CIS Insulin Market, By Source |
6.3.1 Overview and Analysis |
6.3.2 Philippines CIS Insulin Market Revenues & Volume, By Analog, 2021- 2031F |
6.3.3 Philippines CIS Insulin Market Revenues & Volume, By Human Recombinant, 2021- 2031F |
7 Philippines CIS Insulin Market Import-Export Trade Statistics |
7.1 Philippines CIS Insulin Market Export to Major Countries |
7.2 Philippines CIS Insulin Market Imports from Major Countries |
8 Philippines CIS Insulin Market Key Performance Indicators |
8.1 Number of diabetes cases diagnosed annually |
8.2 Adoption rate of insulin therapy among diabetic patients |
8.3 Investment in research and development of insulin products |
8.4 Number of healthcare facilities offering insulin therapy |
8.5 Rate of technological adoption in insulin delivery devices |
9 Philippines CIS Insulin Market - Opportunity Assessment |
9.1 Philippines CIS Insulin Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 Philippines CIS Insulin Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.3 Philippines CIS Insulin Market Opportunity Assessment, By Source, 2021 & 2031F |
10 Philippines CIS Insulin Market - Competitive Landscape |
10.1 Philippines CIS Insulin Market Revenue Share, By Companies, 2024 |
10.2 Philippines CIS Insulin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |